[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339005-105":59,"doc-detail-339005-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","targeting-dhx9-triggers-tumor-intrinsic-interferon-response-and-replication-stress-in-small-cell-lung-cancer","Targeting DHX9 Triggers Tumor-Intrinsic Interferon Response and Replication Stress in Small Cell Lung Cancer","","Activating innate immunity in cancer cells through cytoplasmic nucleic acid sensing—viral mimicry—offers an approach to convert immunologically “cold” tumors into “hot” ones. Using a curated CRISPR screen of RNA helicases, the study identifies DHX9 as a strong repressor of double-stranded RNA in small cell lung cancer. DHX9 depletion promotes cytoplasmic dsRNA buildup and tumor-intrinsic innate immune activation; DHX9 loss also causes R-loop accumulation, DNA damage–derived cytoplasmic DNA, and replication stress. In vivo, DHX9 deletion reduces tumor growth, reshapes the tumor microenvironment toward immunogenicity, and enhances immune-checkpoint blockade responsiveness. Overall, DHX9 emerges as a promising target for SCLC and other genomic instability-driven cold tumors.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/targeting-dhx9-triggers-tumor-intrinsic-interferon-response-and-replication-stress-in-small-cell-lung-cancer/339005/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/targeting-dhx9-triggers-tumor-intrinsic-interferon-response-and-replication-stress-in-small-cell-lung-cancer/339005.png","ImageObject",300,407,{"name":92,"@type":93},"Anda","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-13","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What role does DHX9 play in small cell lung cancer?","Question",{"text":113,"@type":114},"DHX9 functions as a potent repressor of double-stranded RNA, limiting tumor-intrinsic innate immune activation in small cell lung cancer.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does DHX9 depletion affect nucleic acid sensing and immune activation?",{"text":118,"@type":114},"Reducing DHX9 causes accumulation of cytoplasmic dsRNA and triggers a tumor-intrinsic innate interferon-driven antiviral response.",{"name":120,"@type":111,"acceptedAnswer":121},"What additional effects does DHX9 loss have beyond dsRNA accumulation?",{"text":122,"@type":114},"DHX9 ablation leads to aberrant R-loop accumulation, increasing DNA damage–derived cytoplasmic DNA and replication stress in SCLC.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},339005,1790194584,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":26,"preview_page_count":19,"preview_urls":146},962075006959,"https://ap-avatar.wpscdn.com/avatar/e0002397efbe92a78e?_k=1776741047341049297","RESEARCH ARTICLE  \nTargeting DHX9 Triggers Tumor-Intrinsic Interferon Response and Replication Stress in Small Cell Lung Cancer   \nTakahiko Murayama1,2,3, Jun Nakayama4,5, Xinpei Jiang1,2,3,6, Kenichi Miyata7,8, Alexander D. Morris1,2, Kathy Q. Cai9, Rahul M. Prasad1, Xueying Ma1,2,3, Andrey Efimov10, Neel Belani11, Emily R. Gerstein1,2, Yinfei Tan12, Yan Zhou13, William Kim14,15,16, Reo Maruyama7,17, Kerry S. Campbell1,2,3, Lu Chen1,2, Yibin Yang1,2,3, Siddharth Balachandran3,18, and Israel Cañadas1,2,3  \nABSTRACT  Activating innate immunity in cancer cells through cytoplasmic nucleic acid sensing pathways, a phenomenon known as“viral mimicry,” has emerged as an effective strategy  \nto convert immunologically “cold” tumors into “hot.” Through a curated CRISPR-based screen of RNA helicases, we identified DExD/H-box helicase 9 (DHX9) as a potent repressor of double-stranded RNA (dsRNA) in small cell lung cancers (SCLC). Depletion of DHX9 induced accumulation of cytoplasmic dsRNA and triggered tumor-intrinsic innate immunity. Intriguingly, ablating DHX9 also induced aberrant accumulation of R-loops, which resulted in an increase of DNA damage–derived cytoplasmic DNA and replication stress in SCLCs. In vivo, DHX9 deletion promoted a decrease in tumor growth while inducing a more immunogenic tumor microenvironment, invigorating responsiveness to immune-checkpoint blockade. These findings suggest that DHX9 is a crucial repressor of tumor-intrinsic innate immunity and replication stress, representing a promising target for SCLC and other“cold” tumors in which genomic instability contributes to pathology.  \nSIGNIFICANCE: One promising strategy to trigger an immune response within tumors and enhance immunotherapy efficacy is by inducing endogenous“virus-mimetic” nucleic acid accumulation. Here, we identify DHX9 as a viral-mimicry-inducing factor involved in the suppression of double-stranded RNAsand R-loops and propose DHX9 as a novel target to enhance antitumor immunity.  \nSee related commentary by Chiappinelli, p. 389.  \nINTRODUCTION  \nActivating innate immunity in cancer cells is a potent means by which cold (“immune-desert”or“immune-excluded”) tumors can be turned hot (“immune-inflamed,” in which T cells and other immune cells are positioned near the tumor cells), enhancing responsiveness to immune-checkpoint blockade (ICB) therapies (1–5). One promising strategy to trigger an innate immune  \n1Nuclear Dynamics and Cancer Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania. 2Cancer Epigenetics Institute, Fox Chase Cancer Center, Philadelphia, Pennsylvania. 3Center for Immunology, Fox Chase Cancer Center, Philadelphia, Pennsylvania. 4Laboratory of Integrative Oncology, National Cancer Center Research Institute, Tokyo, Japan.  \n5Department of Oncogenesis and Growth Regulation, Research Institute, Osaka International Cancer Institute, Osaka, Japan. 6Biomedical Science Graduate Program, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania. 7Project for Cancer Epigenomics, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan. 8Cancer Cell Communication Project, NEXT-Ganken Program, Japanese Foundation for Cancer Research, Tokyo, Japan. 9Histopathology Facility, Fox Chase Cancer Center, Philadelphia, Pennsylvania. 10Bio Imaging Facility, Fox Chase Cancer Center, Philadelphia, Pennsylvania. 11Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania. 12Genomics Facility, Fox Chase Cancer Center, Philadelphia, Pennsylvania. 13Biostatistics and Bioinformatics Facility, Fox Chase Cancer Center, Philadelphia, Pennsylvania. 14Moores Cancer Center, UC San Diego, La Jolla, California. 15Center for Novel Therapeutics, UC San Diego, La Jolla, California. 16Department of Medicine, UC San Diego, La Jolla, California. 17Cancer Cell Diversity Project, NEXT-Ganken Program, Japanese Foundation for Cancer Research, Tokyo, Japan. 18Cancer Signaling and Microenvironment Program","cbCaii7hgQJ0vwDc","https://ap.wps.com/l/cbCaii7hgQJ0vwDc","pdf",14373058,24,"English","# Abstract\n# Significance\n# Introduction","[{\"question\":\"What role does DHX9 play in small cell lung cancer?\",\"answer\":\"DHX9 functions as a potent repressor of double-stranded RNA, limiting tumor-intrinsic innate immune activation in small cell lung cancer.\"},{\"question\":\"How does DHX9 depletion affect nucleic acid sensing and immune activation?\",\"answer\":\"Reducing DHX9 causes accumulation of cytoplasmic dsRNA and triggers a tumor-intrinsic innate interferon-driven antiviral response.\"},{\"question\":\"What additional effects does DHX9 loss have beyond dsRNA accumulation?\",\"answer\":\"DHX9 ablation leads to aberrant R-loop accumulation, increasing DNA damage–derived cytoplasmic DNA and replication stress in SCLC.\"}]","Targeting DHX9 Triggers Tumor-Intrinsic Interferon Response and Replication Stress in Small Cell Lung Cancer | PDF",1790027207,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c56026587af309a67f97202ba25e1d47.webp",983,1315,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/75ca1c9fc441e21c670d944cd455d0f8.webp",982,1314,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0588ef910c3be403c0d1916c6534f2fc.webp",981,1312,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cdc8f366cf5b6b4f24b7a978ae7c50ad.webp",980,1311]